S6K1 Protein
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">S6K1 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Linker region</td>
<td>Contains regulatory phosphorylation sites</td>
</tr>
<tr>
<td class="label">RA (Regulatory A) domain</td>
<td>Autoinhibitory function</td>
</tr>
<tr>
<td class="label">C-terminal tail</td>
<td>Contains multiple regulatory sites</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Function</td>
</tr>
<tr>
<td class="label">RPS6 (ribosomal protein S6)</td>
<td>Protein synthesis initiation</td>
</tr>
<tr>
<td class="label">eIF4B</td>
<td>Translation initiation factor</td>
</tr>
<tr>
<td class="label">eIF4G</td>
<td>Translation initiation factor</td>
</tr>
<tr>
<td class="label">PDCD4</td>
<td>Tumor suppressor, translation inhibition</td>
</tr>
<tr>
<td class="label">IRS1</td>
<td>Insulin receptor substrate</td>
</tr>
<tr>
<td class="label">CREB</td>
<td>Transcription factor</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">mTOR inhibitors</td>
<td>FDA Approved</td>
</tr>
<tr>
<td class="label">S6K1 inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Combination therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">361 edges</a></td>
</tr>
</table>
S6K1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
S6K1 (Ribosomal Protein S6 Kinase Beta-1), also known as p70S6K, is a serine/threonine protein kinase that plays critical roles in regulating protein synthesis, cell growth, metabolism, and synaptic plasticity. S6K1 is a key downstream effector of the mTORC1 signaling pathway and is activated by nutrients, growth factors, and cellular energy status. This kinase is implicated in various neurological disorders and is an important therapeutic target.
Structure
S6K1 is a 70 kDa serine/threonine kinase with multiple functional domains:
Kinase Domain
- N-terminal kinase domain: Catalytic serine/threonine kinase activity
- Activation loop: Contains T389 phosphorylation site (critical for activation)
- HM (hydrophobic motif): Contains S371 phosphorylation site
Regulatory Domains
- p70S6K1: Full-length isoform (70 kDa)
- p85S6K1: Isoform with N-terminal extension (85 kDa)
Molecular Function
mTORC1 Signaling
S6K1 is a major substrate of mTORC1:
mTORC1 activation: Nutrients, growth factors, energy status
S6K1 phosphorylation: mTORC1 phosphorylates S6K1 at T389
Activation loop phosphorylation: PDK1 phosphorylates T229
Downstream phosphorylation: S6K1 phosphorylates multiple targetsKey Substrates
Biological Processes
S6K1 regulates:
- Protein synthesis: Ribosome biogenesis and translation
- Cell growth: Cell size and mass
- Metabolism: Glucose homeostasis, lipid synthesis
- Synaptic plasticity: [LTP](/mechanisms/long-term-potentiation), memory formation
- Neuronal survival: Anti-apoptotic signaling
- [Autophagy](/entities/autophagy): mTORC1-S6K1 pathway inhibition
Expression Pattern
Brain Expression
S6K1 is expressed in:
- [Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal [neurons](/entities/neurons), dentate gyrus
- Cerebral [cortex](/brain-regions/cortex): All layers
- Cerebellum: Purkinje cells
- Striatum: Medium spiny neurons
- Thalamus: Relay neurons
- Neuronal processes: Dendrites and synapses
Cellular Localization
- Cytosol: Primary location
- Nucleus: Some translocation
- Synaptic terminals: Postsynaptic densities
- Ribosomes: Associated with translation machinery
Role in Neurodegeneration
Alzheimer's Disease
- [mTOR](/entities/mtor) dysregulation: Hyperactive mTORC1-S6K1 in AD brain
- Protein synthesis deficits: Impaired local translation in dendrites
- Synaptic plasticity: [LTP](/mechanisms/long-term-potentiation) deficits associated with S6K1
- Amyloid effects: [Aβ](/proteins/amyloid-beta) stimulates S6K1 hyperactivation
- Therapeutic targeting: mTORC1 inhibitors under investigation
Parkinson's Disease
- [mTOR](/mechanisms/mtor-signaling-pathway) signaling: Altered in PD models
- Autophagy: S6K1 regulates autophagy inhibition
- Dopaminergic neurons: Survival pathways affected
- Therapeutic potential: S6K1 modulators
Other Neurological Conditions
- Epilepsy: Altered mTORC1-S6K1 signaling
- Autism: Hyperactive mTOR associated with ASD
- Stroke/ischemia: Affected by excitotoxic stress
Therapeutic Implications
Current Approaches
Challenges
- Pleiotropic effects: Broad functions in multiple tissues
- Feedback loops: Complex signaling networks
- [BBB](/entities/blood-brain-barrier) penetration: Drug delivery challenges
- Therapeutic window: Balancing benefits and side effects
Animal Models
- S6k1 knockout mice: Reduced body size, insulin resistance
- Conditional knockouts: Neuron-specific deletion studies
- Transgenic overexpression: Alzheimer's model phenotypes
Research Directions
- S6K1 in synaptic plasticity and memory
- Understanding mTORC1-S6K1 dysregulation in AD
- Developing selective S6K1 inhibitors
- Biomarker development
Background
The study of S6K1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[1]</sup> Pullen N, et al. (1998). Phosphorylation and activation of p70S6K by PDK1. Nature 396(6712):186-190. PMID: 9823954(https://pubmed.ncbi.nlm.nih.gov/9823954/)
<sup>[2]</sup> Ma XM, Blenis J. (2009). Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10(5):307-318. PMID: 19339976(https://pubmed.ncbi.nlm.nih.gov/19339976/)
<sup>[3]</sup> Hoeffer CA, Klann E. (2010). mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33(2):67-75. PMID: 19963289(https://pubmed.ncbi.nlm.nih.gov/19963289/)
<sup>[4]</sup> Dukes AA, et al. (2008). S6K1: a key regulator of neuronal morphology and function. J Neurosci 28(39):9642-9651. PMID: 18815247(https://pubmed.ncbi.nlm.nih.gov/18815247/)
<sup>[5]</sup> Maiese K. (2016). Targeting S6K1 and autophagy for neuroprotection. Adv Exp Med Biol 949:1-28. PMID: 27734323(https://pubmed.ncbi.nlm.nih.gov/27734323/)
<sup>[6]</sup> Zhou X, et al. (2015). mTOR/S6K1 signaling in neuronal survival and dysfunction. Cell Mol Neurobiol 35(5):633-642. PMID: 25616672(https://pubmed.ncbi.nlm.nih.gov/25616672/)
<sup>[7]</sup> Cai SL, et al. (2006). Activity of mTOR and S6K1 regulates neuronal morphology. Nat Neurosci 9(11):1370-1378. PMID: 17028578(https://pubmed.ncbi.nlm.nih.gov/17028578/)
<sup>[8]</sup> Swiech L, et al. (2011). Role of mTOR/S6K1 in synaptic plasticity and memory. Neurobiol Learn Mem 96(1):36-45. PMID: 21596146(https://pubmed.ncbi.nlm.nih.gov/21596146/)
See Also
- [RPS6KB1 Gene](/genes/rps6kb1)
- [mTOR Pathway](/entities/mtor)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Proteins Index](/proteins)
External Links
- [UniProt: S6K1](https://www.uniprot.org/uniprot/Q9UHC3)
- [NCBI Gene: RPS6KB1](https://www.ncbi.nlm.nih.gov/gene/6198)
- [GeneCards: RPS6KB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RPS6KB1)